To further validate the EMSA findings (Figure 5) we interrogated the data reported by Sabo et al., 2014 [18] who investigated the role of c-Myc in a murine model of B-cell lymphoma and that of Walz et al., 2014 [19] who studied the consequences of inducible expression and depletion of c-Myc in human cells and murine tumor models. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.